EUVIMEDEUVIMED entdecken
Crossref

Coacervate Microreactors for Cholesterol-Coupled Nitric Oxide Biocatalysis in Atherosclerosis

Xinling Yao iD, Lin Yang iD, Jixiang Xiao, Haihong Yu, Xiuwen Zheng, Wenjing Li, Shaohong Zhou, Yanan Zeng, Hongyan Li, Zeren Ya, Zao Qiu, Peifeng Guo und 2 weitere

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c12847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Xinling Yao und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Institute of Biomedical Innovation, Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, The MOE Basic R…. Hauptthemen laut MEDLINE: Cholesterol, Nitric Oxide, Atherosclerosis. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Fund for Distinguished Young Scholars of Jiangxi Province, ?Ganpo Talent Program? Innovation Leading Talent Project?Youth Category.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is driven by metabolic dysregulation, particularly aberrant cholesterol accumulation and impaired nitric oxide (NO) signaling. However, most therapeutic strategies address these abnormalities separately, while biomaterials capable of translating pathological metabolic dysregulation into localized biochemical regulation remain limited. Herein, we report MMCoac@ChOx/HRP, a macrophage membrane-camouflaged coacervate microreactor formed via liquid–liquid phase separation (LLPS). The microreactor features a macromolecularly crowded core self-assembled from poly(diallyldimethylammonium chloride) and sulfobutylether-β-cyclodextrin, which enables cholesterol recognition and enrichment of cholesterol oxidase (ChOx) and horseradish peroxidase (HRP). These co-encapsulated enzymes achieve high enrichment efficiencies of 87.5 and 92.1%, respectively, to drive cholesterol oxidation and subsequent NO generation. In simulated body fluid, MMCoac@ChOx/HRP depleted cholesterol levels from 5.0 to 2.9 ± 0.4 mM and generated 12.1 ± 0.8 μM NO within 12 h. In vitro, it significantly attenuated macrophage foam cell formation and promoted endothelial repair. Furthermore, following systemic administration in ApoE–/– mice, MMCoac@ChOx/HRP preferentially accumulated in atherosclerotic aortic plaques, enhanced in situ NO generation, and reduced aortic plaque burden from 27.4 ± 4.5 to 8.2 ± 3.0%. Overall, this study demonstrates a localized metabolic intervention strategy driven by an LLPS-based microreactor. This versatile biomaterial platform effectively modulates the plaque microenvironment, holding great potential for therapeutic interventions against metabolic syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolNitric OxideAtherosclerosisAnimalsMiceCholesterol Oxidasebeta-CyclodextrinsBiocatalysisHorseradish PeroxidaseQuaternary Ammonium CompoundsPolyethylenesMacrophagesHumansPhase Separation

Stichwörter der Autor:innen

atherosclerosischolesterol clearancecoacervate microreactorsliquid–liquid phase separationmacrophage membrane coatingnitric oxide

Substanzen

CholesterolNitric OxideCholesterol Oxidasebeta-CyclodextrinsHorseradish PeroxidaseQuaternary Ammonium Compoundspoly-N,N-dimethyl-N,N-diallylammonium chloridePolyethylenes

Autor:innen und Institutionen

  • School of Pharmacy, Institute of Biomedical Innovation, Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid T…
  • The Second Clinical Medical College of Nanchang University, The Second Affiliated Hospital of Nanchang University, Nanchang330006, China.

ORCID-Profile: Xinling Yao, Lin Yang, Songyang Liu

Förderung

  • National Natural Science Foundation of China
  • Science Fund for Distinguished Young Scholars of Jiangxi Province
  • ?Ganpo Talent Program? Innovation Leading Talent Project?Youth Category

Zitieren

APA

Yao, X., Yang, L., Xiao, J., Yu, H., Zheng, X., Li, W., Zhou, S., Zeng, Y., Li, H., Ya, Z., Qiu, Z., Guo, P., Zou, J., & Liu, S. (2026). Coacervate Microreactors for Cholesterol-Coupled Nitric Oxide Biocatalysis in Atherosclerosis. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c12847

Vancouver

Yao X, Yang L, Xiao J, Yu H, Zheng X, Li W, et al. Coacervate Microreactors for Cholesterol-Coupled Nitric Oxide Biocatalysis in Atherosclerosis. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c12847

BibTeX
@article{Yao2026,
  author = {Yao, Xinling and Yang, Lin and Xiao, Jixiang and Yu, Haihong and Zheng, Xiuwen and Li, Wenjing and Zhou, Shaohong and Zeng, Yanan and Li, Hongyan and Ya, Zeren and Qiu, Zao and Guo, Peifeng and Zou, Jiayan and Liu, Songyang},
  title = {Coacervate Microreactors for Cholesterol-Coupled Nitric Oxide Biocatalysis in Atherosclerosis},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c12847}
}
Kostenlos starten →